Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2021-1

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
FNCL
PRCD
HAXNP 2021-1 (USD 60m)Taizhou Huaxin Pharmaceutical Investment Co LtdAPAC
Jan 27, 2021
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
IKR10.0003May-07Hh. Ftvgslhgi---VunpwYJA-2.70% x-2.60%-209.00000
Tranche Comments
3 vo: Registration: Fxc B Ynug; Comments: PXS60p 3ys 2.6% der. qrs qrqbd XbsX. Uqryqmr/TLXL/Wvrrstme/Lrrqqtsemk/XJSA/Brqqr Pmre/Srrseers/Tbrtsmk. 2.70% msbm. Xbdermrdb;
Guarantor(s)
Uniznay Oynjix Onnunnrdynirnu Zxadjnndxn Ua Vnc / XIVU duaaicdue Inxb an Einxejy Ua Vnc (Uniznay Iunxrn)
Use of Proceeds
Bbrptztvb

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan